UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 2.570

Sortiert nach

Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson's disease

Neurology, 1998-05, Vol.50 (5), p.1323

1998

Link zum Volltext

Verfügbarkeit prüfen

Simulated impacts of historical land cover changes on global climate in northern winter

Climate dynamics, 2000-02, Vol.16 (2-3), p.93-105

2000

Link zum Volltext

Verfügbarkeit prüfen

Huntington's disease: a randomized, controlled trial using the NMDA-antagonist amantadine

Neurology, 2002-09, Vol.59 (5), p.694

2002

Link zum Volltext

Verfügbarkeit prüfen

A2A antagonist prevents dopamine agonist-induced motor complications in animal models of Parkinson's disease

Experimental neurology, 2003-11, Vol.184 (1), p.285-294

2003

Link zum Volltext

Verfügbarkeit prüfen

Tissue transglutaminase catalyzes the formation of alpha‐synuclein crosslinks in Parkinson's disease

The FASEB journal, 2004-05, Vol.18 (7), p.932-934

2004

Link zum Volltext

Verfügbarkeit prüfen

Translating A2A antagonist KW6002 from animal models to parkinsonian patients

Neurology, 2003-12, Vol.61 (11 Suppl 6), p.S107

2003

Link zum Volltext

Verfügbarkeit prüfen

Combined blockade of AMPA and NMDA glutamate receptors reduces levodopa-induced motor complications in animal models of PD

Experimental neurology, 2005-12, Vol.196 (2), p.422-429

2005

Link zum Volltext

Verfügbarkeit prüfen

The Functional Neuroanatomy of Tourette's Syndrome: An FDG PET Study III: Functional Coupling of Regional Cerebral Metabolic Rates

Neuropsychopharmacology (New York, N.Y.), 2002-07, Vol.27 (1), p.92-104

2002

Link zum Volltext

Verfügbarkeit prüfen

Striatal dopamine- and glutamate-mediated dysregulation in experimental parkinsonism

Trends in neurosciences (Regular ed.), 2000-10, Vol.23 (10), p.S86-S91

2000

Link zum Volltext

Verfügbarkeit prüfen

Levodopa-induced dyskinesias improved by a glutamate antagonist in parkinsonian monkeys

Annals of neurology, 1996-05, Vol.39 (5), p.574-578

1996

Link zum Volltext

Verfügbarkeit prüfen

The significance of continuous dopaminergic stimulation in the treatment of Parkinson's disease

Drugs (Basel), 1998, Vol.55, p.1-9

CHASE, T. N

1998

Link zum Volltext

Verfügbarkeit prüfen

Antiparkinsonian and antidyskinetic activity of drugs targeting central glutamatergic mechanisms

Journal of neurology, 2000-04, Vol.247 Suppl 2 (S2), p.II36-II42

2000

Link zum Volltext

Verfügbarkeit prüfen

The influence of anthropogenic landscape changes on weather in south Florida

Monthly weather review, 1999-07, Vol.127 (7), p.1663-1673

1999

Link zum Volltext

Verfügbarkeit prüfen

Dextromethorphan improves levodopa-induced dyskinesias in Parkinson's disease

Neurology, 1998-07, Vol.51 (1), p.203

1998

Link zum Volltext

Verfügbarkeit prüfen

Amantadine reduces levodopa-induced dyskinesias in parkinsonian monkeys

Movement disorders, 1998-09, Vol.13 (5), p.798-802

1998

Link zum Volltext

Verfügbarkeit prüfen

NR2B selective NMDA receptor antagonist CP-101,606 prevents levodopa-induced motor response alterations in hemi-parkinsonian rats

Neuropharmacology, 2004-08, Vol.47 (2), p.184-194

2004

Link zum Volltext

Verfügbarkeit prüfen

Update on a proposed mechanism for the regulation of minimum midtropospheric and surface temperatures in the Arctic and Antarctic

Journal of Geophysical Research - Atmospheres, 2008-12, Vol.113 (D24), p.D24101-n/a

2008

Link zum Volltext

Verfügbarkeit prüfen

Enhanced tyrosine phosphorylation of striatal NMDA receptor subunits: effect of dopaminergic denervation and l-DOPA administration

Brain research, 1998-11, Vol.813 (1), p.150-159

1998

Link zum Volltext

Verfügbarkeit prüfen

Neostriatal mechanisms in Parkinson's disease

Neurology, 1998-08, Vol.51 (2 Suppl 2), p.S30

1998

Link zum Volltext

Verfügbarkeit prüfen

Intravenous amantadine improves levadopa-induced dyskinesias: An acute double-blind placebo-controlled study

Movement disorders, 2001-05, Vol.16 (3), p.515-520

2001

Link zum Volltext

Verfügbarkeit prüfen

Wearing-off fluctuations in Parkinson's disease: Contribution of postsynaptic mechanisms

Annals of neurology, 1994-07, Vol.36 (1), p.27-31

1994

Link zum Volltext

Verfügbarkeit prüfen

Glutamate-mediated striatal dysregulation and the pathogenesis of motor response complications in Parkinson's disease

Amino acids, 2002-01, Vol.23 (1-3), p.133-139

2002

Link zum Volltext

Verfügbarkeit prüfen

D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons

Science (American Association for the Advancement of Science), 1990-12, Vol.250 (4986), p.1429-1432

1990

Link zum Volltext

Verfügbarkeit prüfen

Kainic Acid‐Induced Apoptosis in Rat Striatum Is Associated with Nuclear Factor‐κB Activation

Journal of neurochemistry, 2000-02, Vol.74 (2), p.647-658

2000

Link zum Volltext

Verfügbarkeit prüfen

Effect of dopamine denervation and dopamine agonist administration on serine phosphorylation of striatal nmda receptor subunits

Brain research, 1999-03, Vol.821 (2), p.433-442

1999

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 2.570

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.131)
Mit Volltextzugriff
(2.146)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.485)
Life Sciences & Biomedicine
(1.131)
Humans
(785)
Male
(570)
Biological And Medical Sciences
(479)
Female
(467)
Animals
(407)
Neurosciences & Neurology
(347)
Medical Sciences
(329)
Middle Aged
(308)
Adult
(237)
Physical Sciences
(237)
Aged
(223)
Clinical Neurology
(203)
Neurosciences
(197)
Rats
(190)
Technology
(178)
Fundamental And Applied Biological Sciences. Psychology
(160)
Social Sciences
(124)
Physics
(123)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson's disease

Simulated impacts of historical land cover changes on global climate in northern winter

Huntington's disease: a randomized, controlled trial using the NMDA-antagonist amantadine

A2A antagonist prevents dopamine agonist-induced motor complications in animal models of Parkinson's disease

Tissue transglutaminase catalyzes the formation of alpha‐synuclein crosslinks in Parkinson's disease

Translating A2A antagonist KW6002 from animal models to parkinsonian patients

Combined blockade of AMPA and NMDA glutamate receptors reduces levodopa-induced motor complications in animal models of PD

The Functional Neuroanatomy of Tourette's Syndrome: An FDG PET Study III: Functional Coupling of Regional Cerebral Metabolic Rates

Striatal dopamine- and glutamate-mediated dysregulation in experimental parkinsonism

Levodopa-induced dyskinesias improved by a glutamate antagonist in parkinsonian monkeys

The significance of continuous dopaminergic stimulation in the treatment of Parkinson's disease

Antiparkinsonian and antidyskinetic activity of drugs targeting central glutamatergic mechanisms

The influence of anthropogenic landscape changes on weather in south Florida

Dextromethorphan improves levodopa-induced dyskinesias in Parkinson's disease

Amantadine reduces levodopa-induced dyskinesias in parkinsonian monkeys

NR2B selective NMDA receptor antagonist CP-101,606 prevents levodopa-induced motor response alterations in hemi-parkinsonian rats

Update on a proposed mechanism for the regulation of minimum midtropospheric and surface temperatures in the Arctic and Antarctic

Enhanced tyrosine phosphorylation of striatal NMDA receptor subunits: effect of dopaminergic denervation and l-DOPA administration

Neostriatal mechanisms in Parkinson's disease

Intravenous amantadine improves levadopa-induced dyskinesias: An acute double-blind placebo-controlled study

Wearing-off fluctuations in Parkinson's disease: Contribution of postsynaptic mechanisms

Glutamate-mediated striatal dysregulation and the pathogenesis of motor response complications in Parkinson's disease

D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons

Kainic Acid‐Induced Apoptosis in Rat Striatum Is Associated with Nuclear Factor‐κB Activation

Effect of dopamine denervation and dopamine agonist administration on serine phosphorylation of striatal nmda receptor subunits

Suchergebnisse filtern